Longer-term mortality and kidney outcomes of participants in the combination antibiotics for methicillin-resistant Staphylococcus aureus (CAMERA2) trial: a post hoc analysis

• Main Authors: Legg, Amy, Roberts, Matthew A., Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon Benattar, Yael, Yahav, Dafna, Paul, Mical, Chen, Xinxin, Yeo, He Ping, Lye, David C., Lee, Russel, Robinson, J. Owen, Foo, Hong, Tramontana, Adrian R., Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O'Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E., Dotel, Ravindra, Chia, Timothy, Archuleta, Sophia, Smith, Simon, Warner, Morgyn S., Titin, Christina, Kalimuddin, Shirin, Roberts, Jason A., Tong, Steven Y. C., Davis, Joshua S.
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2023
• Subjects: Science::Medicine; Acute Kidney Injury; Nephrotoxicity
• Online Access: https://hdl.handle.net/10356/171771
• Institution: Nanyang Technological University

Background: The Combination Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus (CAMERA2) trial ceased recruitment in July 2018, noting that a higher proportion of patients in the intervention arm (combination therapy) developed acute kidney injury (AKI) compared to the standard thera...